Could gut bacteria play a role in late-life depression?
Modestly, yes. In this pilot randomized trial of 58 adults aged 60 and older starting treatment for moderate depression, adding a daily probiotic to standard antidepressant care produced modest overall advantages in depression and anxiety scores compared with placebo. Quality of life improved substantially in both groups, and the probiotic added nothing beyond that.
Depression in older adults is common, and it can be stubborn. Standard antidepressants help many people, but response rates in older patients run around 50 percent, and side effect risks are higher. That has pushed researchers to look beyond the brain itself. One target is the gut. The idea is that the bacteria living in your digestive tract communicate with your brain through what scientists call the gut-brain axis. This trial tested whether adding a probiotic to newly started antidepressant treatment could improve outcomes.
How the study worked
Researchers ran a randomized, double-blind, placebo-controlled pilot trial at two tertiary care hospitals in India, conducted between 2023 and 2025. Randomized means people were assigned to groups by chance. Double-blind means neither the patients nor the treating clinicians, outcome assessors, or data analysts knew who received the real probiotic and who received the placebo. The capsules were identical in appearance, flavor, and smell.
Of 735 people assessed for eligibility, 58 were randomized, 29 to each group. All were aged 60 or older with moderate unipolar depression, defined as an episode lasting at least two weeks with a Montgomery-Asberg Depression Rating Scale score of 20 to 34. Importantly, none of them were already established on antidepressants for the current episode. They were either antidepressant-naive or had washed out prior therapy, so standard antidepressant treatment was started at enrollment for everyone. On top of that, half received a daily probiotic capsule and half received a matching placebo for 12 weeks. The probiotic contained at least 3 billion colony-forming units each of Lactobacillus helveticus and Bifidobacterium longum, roughly 6 billion units per day, taken once after dinner. Everyone was then followed for another 12 weeks, out to 24 weeks total. Medication adherence exceeded 80 percent in both groups.
People with psychotic symptoms, high suicide risk, significant cognitive impairment, chronic neurological disease, active substance abuse, or gastrointestinal conditions such as irritable bowel syndrome were excluded.
What the data show
Both groups improved over time. Depression scores fell significantly across the trial (F = 32.0, p < 0.001), and so did anxiety scores on the GAD-7 (F = 13.1, p < 0.001). That is what you would expect when antidepressant treatment is started in people who were not on it.
The probiotic group’s overall scores were lower than the placebo group’s on both measures: depression (F = 12.7, p = 0.001) and anxiety (F = 10.7, p = 0.002). But the group-by-time interactions were not significant, meaning the two groups’ trajectories over 24 weeks ran largely parallel. The probiotic group sat somewhat better overall rather than pulling away as the weeks went on.
The researchers also measured changes in the body. Serum brain-derived neurotrophic factor, or BDNF, was significantly higher in the probiotic group. BDNF is a protein that supports the growth and health of brain cells. Stool testing also showed increased abundance of the two supplemented strains in the probiotic group, confirming the capsules were doing what they were meant to do in the gut.
Quality of life improved markedly in both groups across physical, psychological, environmental, and social domains (all F > 100, p < 0.001). The probiotic added no extra benefit there. Antidepressant dose, expressed as escitalopram equivalents, and benzodiazepine use influenced some of the outcomes.
Dr. Kumar’s Take
I find this study interesting, but I want to be honest about what it does and does not show. The gut-brain axis has been one of the more compelling ideas in psychiatry over the past decade, and it is good to see a controlled human trial rather than only animal work. The BDNF result and the confirmed change in gut bacteria give the mood findings some biological grounding.
That said, this is a pilot trial of 58 people, and the authors say so plainly. No formal power calculation was done. More than half of the participants dropped out over the 24 weeks, which is a serious limitation, and missing data were extensive enough that a proper intention-to-treat analysis with imputation could not be performed. The parallel trajectories matter to me too: the probiotic group did better overall, but the two groups did not diverge over time the way you would want to see if the supplement were adding real momentum.
I would not tell my older patients to swap or delay antidepressant treatment for a probiotic. Everyone in this trial started an antidepressant. The probiotic was tested as an addition to that, and the honest reading is that it is a promising adjunct worth testing in a larger trial, not an established treatment.
Who might benefit most
This trial focused on a specific group: adults aged 60 and older with moderate unipolar depression who were starting standard antidepressant treatment, either for the first time in this episode or after washing out prior therapy. The probiotic was tested as an addition to that treatment, not as a replacement for it.
It is worth remembering what the study did not test. It did not enroll younger adults, people with severe depression or psychotic symptoms, people at high suicide risk, or people with significant cognitive impairment. It also did not test probiotics used alone without antidepressant medication, or in people already stable on an antidepressant. These findings are narrow by design.
Practical Takeaways
- Talk to your doctor before adding any probiotic for mood, since this trial tested two specific strains as an addition to antidepressant treatment, not as a standalone therapy.
- If you are starting treatment for depression, the antidepressant is the intervention with the evidence behind it here. Everyone in this trial received one.
- Set realistic expectations. The probiotic group scored better overall on depression and anxiety, but the two groups improved along largely parallel paths and quality of life improved just as much without the supplement.
- Wait for larger studies before spending money on probiotics for depression. This was a pilot trial of 58 people with more than half lost to follow-up by 24 weeks.
Related Studies and Research
- Probiotic add-on therapy for depression: clinical and neural effects
- Over-the-counter products for depression, anxiety, and insomnia in older adults
- Single-dose psilocybin vs placebo: first double-blind depression trial
- Antidepressant efficacy of Sudarshan Kriya Yoga in melancholia: a randomized comparison with ECT and imipramine
FAQs
What is the gut-brain axis, and why does it matter for depression?
The gut-brain axis is the two-way communication network linking the digestive system, the immune system, and the central nervous system. Gut microbes can produce neuroactive compounds such as serotonin and gamma-aminobutyric acid, which act on the vagus and enteric nerves. Stress and activation of the hypothalamic-pituitary-adrenal axis can disrupt gut barrier integrity and alter the microbiota. In this trial, the probiotic group had higher serum BDNF and more of the supplemented strains in stool, which supports a biologically plausible route from gut to brain. Data on probiotics in older adults with clinical depression have been scarce, which is why this pilot was run.
Can I just buy a probiotic at the store to treat my depression?
Not based on this study. The trial used specific strains, Lactobacillus helveticus and Bifidobacterium longum, at roughly 6 billion colony-forming units per day, given alongside antidepressant treatment that was started at the same time. Probiotic strains and doses differ widely between products, and what was tested here may not match what is on a shelf. If you are dealing with depression, talk with your doctor rather than self-treating with a supplement.
Why did depression scores improve but quality of life show no probiotic benefit?
Quality of life did improve, and it improved a great deal in both groups. The point is that the probiotic added nothing to it. Depression rating scales track specific symptoms such as low mood, sleep, and worry. Quality of life captures something broader across physical, psychological, social, and environmental domains. Both groups had started antidepressant treatment, and that appears to account for the quality-of-life gains on its own.
Bottom Line
In this pilot trial of 58 older adults starting treatment for moderate depression, adding a daily probiotic to standard antidepressant care produced modest overall advantages on depression and anxiety scores, along with higher serum BDNF and confirmed changes in gut bacteria. But the two groups improved along largely parallel paths over 24 weeks, quality of life improved just as much without the supplement, and more than half of the participants were lost to follow-up. The study keeps the gut-brain axis alive as a target in late-life depression. It is not a reason to substitute a supplement for medication.
